Integrated approach to lung screening and quitting for African Americans
Official title: Effectiveness of a multilevel integrated intervention for LDCT lung cancer screening and smoking cessation among African Americans
Funded at Lsu Health Sciences Center · NIH-11491488 · Data updated 2026-11-12
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 23, 2024 |
| Project end | July 15, 2030 |
| Funding year | 2026 |
| Award (this year) | $617,379 |
| NIH project number | 5R01MD019690-02 |
| Project ID | NIH-11491488 on NIH RePORTER |
Who could benefit from this research
✓Could help
African American adults aged 50–80 with a minimum 20 pack-year history who are current or former smokers.
✕Less likely to help
Individuals outside the eligible age range or without a significant smoking history may not benefit.
What this research studies
This project targets African American adults 50–80 who smoke, combining culturally relevant outreach, screening reminders, and smoking-cessation support. It uses a multi-level intervention at the individual, community, and system levels to improve LDCT uptake and quitting rates. The goal is to reduce lung cancer disparities by making screening and cessation more accessible and acceptable within African American communities. Results will come from real-world implementation in academic medical centers, with active follow-up and adherence tracking.
Why it matters
Potential benefit: If successful, the program could reduce lung cancer deaths in African American communities by increasing screening and helping more people quit smoking.
How similar studies have gone: Prior studies show that culturally tailored, community-engaged approaches can improve cancer screening and cessation behaviors, though integrated LDCT plus cessation programs in this population are still being tested.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Tseng, Tung Sung — Lsu Health Sciences Center
- Study coordinator: Tseng, Tung Sung
Related research
Other NIH-funded projects on the same topics.
-
Personalized lung cancer risk tool to boost screening and help people quit smoking
This project uses a personalized risk profile to help current and former smokers—particularly underserved and African American patients—get lung cancer screening and stop smoking.
-
Improving lung cancer screening and smoking cessation for at-risk patients
This study is looking to help current and former smokers, especially those in underserved communities like African Americans, get better access to lung cancer screenings and support to quit smoking by using a special tool that helps doctors and patients talk about their lung cancer risks and treatment options in a more
-
Improving lung cancer screening and smoking cessation for African Americans
This study is looking for ways to make lung cancer screenings and quitting smoking easier and more effective for African Americans, who are at a higher risk for lung cancer, by combining special screenings with personalized support to help them stop smoking.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.